Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Beijing Vagary Pharmaceutical Technology Ltd. operates within the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This action is being processed in 1 distinct art unit, indicating a focused technical area for the current filing. The presence of 1 pending office action shows a targeted approach to securing patent protection in the pharmaceutical sector.
The prosecution is overseen by 1 distinct examiner, ATKINSON, JOSHUA ALEXANDER. ATKINSON, JOSHUA ALEXANDER is the busiest examiner for the company, with 1 pending office action. The company's current patent activity is highly focused, as it involves only 1 distinct examiner and 1 distinct art unit in the pharmaceutical sector. For practitioners, this means that the outcome of the company's current patent efforts depends entirely on the review of this individual examiner.
The alignment of the pending office action with 1 distinct examiner and 1 distinct art unit reflects a streamlined prosecution footprint. This structure may allow for a more consistent dialogue between the applicant and the office, as there are no competing matters across different examiners or units. The focus on Biotechnology & Pharmaceuticals ensures that the prosecution remains within a specialized technical domain, overseen by ATKINSON, JOSHUA ALEXANDER.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ATKINSON, JOSHUA ALEXANDER | 1 | 52.4% | +26.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706573 | Minitablet, Preparation Method Thereof, and Formulation | ATKINSON, JOSHUA ALEXANDER | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18706573 | Minitablet, Preparation Method Thereof, and Formulation | ATKINSON, JOSHUA ALEXANDER | — |
| Art Unit | Apps |
|---|---|
| 1612 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18706573 | Minitablet, Preparation Method Thereof, and Formulation | ATKINSON, JOSHUA ALEXANDER | 1612 | §103§112 | Non-Final OA | — | Pending | Jul 10, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial